Key Statistics for GENT
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (EUR) (ttm)
|Est. EPS (EUR) (12/2013)
|Est. PEG Ratio
|Market Cap (M USD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for GENT
- Net Income (M/EUR)
Gentium Spa is a biopharmaceutical company focused on the discovery, research, development and manufacture of drugs for the treatment and prevention of a variety of vascular diseases and conditions related to cancer and cancer treatments.
More Company Profile & Key Executives for GENT
|Khalid IslamChairman/CEO||Salvatore CalabreseCFO/COO|
|Carin HeringaSenior VP/Scientific Dir||Adrian J HaighVP:Commercial Operations|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.